Pfizer Agrees to Pay $68 Billion for Rival Wyeth
By ANDREW ROSS SORKIN and DUFF WILSON 8:39 AM ET
The deal creating a pharmaceutical behemoth is the first big merger backed by Wall Street in months.
- MarketWatch – NewsWatch: U.S. stock futures flattish as Caterpillar warns, Pfizer deals
- WSJ Health Blog – Live Blogging the Pfizer-Wyeth Analyst Call
- Instapundit – THE PFIZER-WYETH MERGER LOOKS LIKE IT’S HAPPENING. Here are some thoughts from Derek Lowe.
- Seattle Times – Pfizer agrees to buy Wyeth for $68 billion
- Financial Times – Pfizer deal helps temper gloom on Wall St
- Reuters – A trigger for more drug deals?
- In the Pipeline – Pfizer / Wyeth: Different This Time?
- Los Angeles Times – Pfizer to buy Wyeth for $68 billion, cut jobs
From the New York Times’ “Extra” box on the Pfizer-Wyeth merger. Times Extra “links you to coverage from other news sources and blogs, directly from our home page.”
